Metastatic osteosarcoma
Information
- Disease name
- Metastatic osteosarcoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01590069 | Active, not recruiting | Phase 1 | Aerosolized Aldesleukin in Treating Patients With Lung Metastases | June 28, 2012 | April 30, 2026 |
| NCT02243605 | Active, not recruiting | Phase 2 | Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma | December 19, 2014 | June 30, 2024 |
| NCT00093821 | Completed | Phase 1 | Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors | September 2004 | |
| NCT00134030 | Completed | Phase 3 | Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma | November 14, 2005 | September 30, 2022 |
| NCT00330421 | Completed | Phase 2 | Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) | June 2006 | July 2008 |
| NCT00954473 | Completed | Study of Blood Samples From Patients With Osteosarcoma | January 2009 | ||
| NCT01016015 | Completed | Phase 2 | Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma | November 2009 | July 2014 |
| NCT01154452 | Completed | Phase 1/Phase 2 | Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma | June 2010 | February 2015 |
| NCT01190943 | Completed | DNA Biomarkers in Tissue Samples From Patients With Osteosarcoma | August 6, 2010 | ||
| NCT01374672 | Completed | Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma | July 2011 | September 2011 | |
| NCT01553539 | Completed | Phase 2 | Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery | October 2009 | January 2013 |
| NCT01804374 | Completed | Phase 2 | Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma | June 2011 | December 2014 |
| NCT01807052 | Completed | Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas | November 2009 | May 2016 | |
| NCT00004241 | Completed | Phase 1 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma | October 1999 | |
| NCT00023998 | Completed | Phase 2 | Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma | July 2001 | May 2007 |
| NCT02357810 | Completed | Phase 2 | Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas | March 21, 2015 | October 12, 2021 |
| NCT02470091 | Completed | Phase 2 | Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma | November 21, 2015 | December 31, 2023 |
| NCT02484443 | Completed | Phase 2 | Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma | February 4, 2016 | September 30, 2023 |
| NCT04854018 | Completed | Phase 4 | Indo-cyanine Green (ICG) in Paediatric Oncology MIS | April 30, 2021 | September 30, 2022 |
| NCT05235165 | Recruiting | Phase 3 | Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma | April 1, 2022 | March 31, 2031 |
| NCT06228326 | Recruiting | Phase 1 | A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs | April 17, 2024 | February 2027 |
| NCT04668300 | Recruiting | Phase 2 | Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma | November 26, 2020 | June 30, 2024 |
| NCT05019703 | Suspended | Phase 2 | Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study | April 25, 2023 | December 31, 2027 |
| NCT05691478 | Suspended | Phase 2/Phase 3 | A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma | March 3, 2023 | March 20, 2030 |
| NCT01886105 | Terminated | Phase 2 | Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma | August 19, 2013 | June 11, 2017 |
| NCT01759303 | Terminated | Phase 2 | Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung | April 2013 | May 2017 |